Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications

Cancer Epidemiology

Volumn 39, Issue 3, 2015, Pages 284-290

  Sartorius, K ^a,b   Sartorius, B ^b   Aldous, C ^b   Govender, P S ^b   Madiba, T E ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Alcohol; Determinants; Hepatitis B and C; Hepatocellular (liver) carcinoma; Incidence; Spatial risk; Under reporting

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGED; ARTICLE; ASIA; CANCER INCIDENCE; CHILD; DEVELOPING COUNTRY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INFANT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SOUTH AMERICA; CARCINOMA, HEPATOCELLULAR; HEALTH; INCIDENCE; LIVER NEOPLASMS; PREVALENCE; STATISTICS AND NUMERICAL DATA;

CARCINOMA, HEPATOCELLULAR; GLOBAL HEALTH; HUMANS; INCIDENCE; LIVER NEOPLASMS; PREVALENCE; RISK FACTORS;

EID: 84929948628     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.04.006     Document Type: Article

References (47)

1. Venook A.P., Papandreou C., Furuse J., de Guevara L.L. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010, 15:5-13.
2. Cancer IAfRo.Globocan Estimated cancer incidence, mortality and prevalence worldwide in 2012 2012, 9. World Health Organization, http://globocan iarc fr/Pages/fact_sheets_cancer aspx [accessed 2014].
3. di Bisceglie A.M. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 2004, 127:S104-S107.
4. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
5. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142. 1264.e1-1273.e1.
6. Gomaa A.I., Khan S.A., Toledano M.B., Waked I., Taylor-Robinson S.D. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenter 2008, 14:4300.
7. Caldwell S., Park S.H. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 2009, 44:96-101.
8. Chen L., Magliano D.J., Zimmet P.Z. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2012, 8:228-236.
9. Fan J.G., Saibara T., Chitturi S., Kim B.I., Sung J.J., Chutaputti A. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific. J Gastroenterol Hepatol 2007, 22:794-800.
10. Kew M.C. Hepatocellular carcinoma in African Blacks: recent progress in etiology and pathogenesis. World J Hepatol 2010, 2:65.
11. Nordenstedt H., White D.L., El-Serag H.B. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010, 42:S206-S214.
12. Seeff L., Hoofnagle J. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 2006, 25:3771-3777.
13. Sherman M. Epidemiology of hepatocellular carcinoma. Oncology 2010, 78:7-10.
14. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Seminars in liver diseases 2005, 143-154. Thieme-Stratton, New York, c1981.
15. Wulfkuhle J.D., Liotta L.A., Petricoin E.F. Proteomic applications for the early detection of cancer. Nat Rev Cancer 2003, 3:267-275.
16. Ma S., Chan K.W., Hu L., Lee T.K.W., Wo J.Y.H., Ng I.O.L., et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
17. Gilks C.F., Crowley S., Ekpini R., Gove S., Perriens J., Souteyrand Y., et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006, 368:505-510.
18. Curado M., Edwards B., Shin H., Storm H., Ferlay J., Heanue M., et al. IARC scientific publications no. 160 2007, vol. IX. IARC, Lyon.
19. Forman D., Bray F., Brewster D., Gombe Mbalawa C., Kohler B., Piñeros M., et al. Cancer incidence in five continents 2013, vol. X.X. IARC, Lyon, France.
20. Luengo-Fernandez R., Leal J., Gray A., Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 2013, 14:1142-1143.
21. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498.
22. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
23. Organization WH Global blood safety and availability. Facts and figures from the 2007 Blood Safety Survey, 2009 2010.
24. Franco E., Bagnato B., Marino M.G., Meleleo C., Serino L., Zaratti L., et al. Epidemiology and prevention in developing countries. World J Hepatol 2012, 4:74.
25. Garg R., Kauppi C., Lewko J., Urajnik D. A structural model of educational aspirations. J Career Dev 2002, 29:87-108.
26. Global information system on alcohol and health (GISAH) 2011, Organization WH, World Health Organization, Geneva, [online database].
27. Ng M., Freeman M.K., Fleming T.D., Robinson M., Dwyer-Lindgren L., Thomson B., et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014, 311:183-192.
28. WHO The global burden of disease 2004 2008, World Health Organization.
29. StataCorp Stata statistical software: release 13 2013, StataCorp LP, College Station, TX.
30. Pickle L.W., Mason T., Howard N., Hoover R., Fraumeni J. Atlas of US cancer mortality among whites: 1950-1980 1987, US Department of Health and Human Services, Public Health Service, National Institutes of Health.
31. Shorrocks A.F. Decomposition procedures for distributional analysis: a unified framework based on the Shapley value. J Econ Inequal 2013, 1-28.
32. MapInfo Corporation MapInfo professional: version 9.5 2008, Pitney Bowes Software, Stamford, USA.
33. Forman D., Bray F., Brewster D., Gombe Mbalawa C., Kohler B., Piñeros M., et al. Cancer incidence in five continents 2013, vol. X. IARC, Lyon, [electronic version].
34. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745-750.
35. Di Bisceglie A.M. Hepatitis C and hepatocellular carcinoma. Hepatology 1997, 26. 34S-8S.
36. Kew M.C. Hepatocellular carcinoma in developing countries: prevention, diagnosis and treatment. World J Hepatol 2012, 4:99.
37. Binagwaho A., Wagner C.M., Gatera M., Karema C., Nutt C.T., Ngabo F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 2012, 90:623-628.
38. Heffernan M.E., Garland S.M., Kane M.A. Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience. Sex Health 2010, 7:383-390.
39. Bruix J., Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002, 35:519-524.
40. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.
41. Forner A., Llovet J.M., Bruix J. Hepatocellular carcinoma. Lancet 2012, 379:1245-1255.
42. Farmer P., Frenk J., Knaul F.M., Shulman L.N., Alleyne G., Armstrong L., et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
43. Valsecchi M.G., Steliarova-Foucher E. Cancer registration in developing countries: luxury or necessity. Lancet Oncol 2008, 9:159-167.
44. Mindel S. Role of imager in developing world. Lancet 1997, 350:426-429.
45. Yang J.D., Roberts L.R. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010, 7:448-458.
46. Kassahun W., Hauss J. Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 2008, 62:1271-1278.
47. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res 2001, 10:195-216.